NEW YORK (GenomeWeb) – Great Basin Scientific said today that its Shiga Toxin Direct Test has garnered CE IVD marking, qualifying it for distribution in more than 32 countries across Europe.

The assay, which was approved by the US Food and Drug Administration in March, uses PCR to detect Shiga toxin-producing Escherichia coli (STEC) and serotype O157 directly from patient specimens. Specifically, the assay detects the stx1 and stx2 genes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.